ALLO Latest Press Releases

-- November 10, 2025 --

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- November 6, 2025 --

Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update Globe Newswire 4:05 PM

-- November 3, 2025 --

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting Globe Newswire 9:04 AM

-- October 30, 2025 --

Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update Globe Newswire 8:30 AM

-- August 27, 2025 --

Allogene Therapeutics Announces Participation in Upcoming Investor Conference Globe Newswire 8:30 AM

-- August 13, 2025 --

Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update Globe Newswire 4:05 PM

-- August 6, 2025 --

Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update Globe Newswire 8:30 AM

-- August 1, 2025 --

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software